Nocardia vulneris: A rare pathogen in actinomycetoma - A case report and review of the literature
item.page.dc.date.issued
2025-08-01
item.page.dc.type
item.page.dc.identifier.eissn
2690442X
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105012565360
item.page.oaire.citation.title
Skin Health and Disease
item.page.oaire.citation.volume
5
item.page.oaire.citation.issue
4
item.page.oaire.citation.startPage
297
item.page.oaire.citation.endPage
302
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Skin Health and Disease Vol.5 No.4 (2025) , 297-302
punsarn.item.page.citation
Rattananukrom T., Arenas R., Ramírez Y., Luz Ely Guevara-Cerritos A., Hernandez-Castro R. Nocardia vulneris: A rare pathogen in actinomycetoma - A case report and review of the literature. Skin Health and Disease Vol.5 No.4 (2025) , 297-302. 302. doi:10.1093/skinhd/vzaf041 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111639
item.page.dc.title
Nocardia vulneris: A rare pathogen in actinomycetoma - A case report and review of the literature
item.page.dc.contributor.author
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Actinomycetoma is a chronic, progressive bacterial infection characterized by granuloma formation, with Nocardia vulneris being a rare causative agent. A 32-year-old healthy man from El Salvador presented with painless nodules, scars and discharging sinus tracts on his back. Examination of the exudate revealed small white grains, and Nocardia species were isolated through culture. Molecular identification of N. vulneris was confirmed via 16S rDNA gene amplification and sequencing. The patient was treated with trimethoprim-sulfamethoxazole and dapsone, resulting in significant clinical improvement after 6 months. He continues on this treatment regimen. This case highlights the rarity of N. vulneris mycetoma at an unusual anatomical site and demonstrates the effectiveness of combined trimethoprim-sulfamethoxazole and dapsone therapy.